NDC 71335-0161-08 - Phentermine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71335-0161
- Requested NDC
- 71335-0161-08
- Package NDCs from labels
- 71335-0161-2, 71335-0161-8, 71335-0161-5, 71335-0161-0, 71335-0161-6, 71335-0161-3, 71335-0161-9, 71335-0161-4, 71335-0161-1, 71335-0161-7, 71335-0161-08
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2024-08-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Phentermine Hydrochloride - Bryant Ranch Prepack | Bryant Ranch Prepack | 2024-08-08 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71335-0161-0 | Phentermine Hydrochloride | 90 in 1 BOTTLE | TABLET | 90 | 10 | |
| 71335-0161-1 | Phentermine Hydrochloride | 30 in 1 BOTTLE | TABLET | 30 | 10 | |
| 71335-0161-2 | Phentermine Hydrochloride | 15 in 1 BOTTLE | TABLET | 15 | 10 | |
| 71335-0161-3 | Phentermine Hydrochloride | 28 in 1 BOTTLE | TABLET | 28 | 10 | |
| 71335-0161-4 | Phentermine Hydrochloride | 7 in 1 BOTTLE | TABLET | 7 | 10 | |
| 71335-0161-5 | Phentermine Hydrochloride | 14 in 1 BOTTLE | TABLET | 14 | 10 | |
| 71335-0161-6 | Phentermine Hydrochloride | 60 in 1 BOTTLE | TABLET | 60 | 10 | |
| 71335-0161-7 | Phentermine Hydrochloride | 45 in 1 BOTTLE | TABLET | 45 | 10 | |
| 71335-0161-8 | Phentermine Hydrochloride | 2 in 1 BOTTLE | TABLET | 2 | 10 | |
| 71335-0161-9 | Phentermine Hydrochloride | 21 in 1 BOTTLE | TABLET | 21 | 10 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71335-0161 | PHENTERMINE HYDROCHLORIDE TABLET [BRYANT RANCH PREPACK] | 10 | Current NDC, Legacy NDC, 10 package rows | 20240809_bd7393cb-2b72-4ecd-ba03-801b635b7647.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71335-0161-0 | EA - Each | 71335-0161 | 55567e73-664a-45b6-a2c2-bf84ae0c9a34 | 1 | 2018-03-08 |
| 71335-0161-1 | EA - Each | 71335-0161 | af0a9579-97f5-4ad2-8ffb-e09bdd0e6638 | 1 | 2018-03-08 |
| 71335-0161-2 | EA - Each | 71335-0161 | 7e901ea6-48a2-4953-b9f1-d221f754d24a | 1 | 2018-03-08 |
| 71335-0161-3 | EA - Each | 71335-0161 | f7a37ef9-608f-4e41-ad3f-3b60ce18304e | 1 | 2018-03-08 |
| 71335-0161-4 | EA - Each | 71335-0161 | 2177a1e6-772a-47a6-93ea-46410878abc9 | 1 | 2018-03-08 |
| 71335-0161-5 | EA - Each | 71335-0161 | 497b2b76-bc00-4e0b-999c-0443f0b9220e | 1 | 2018-03-08 |
| 71335-0161-6 | EA - Each | 71335-0161 | 914321dc-5b2e-433e-8e7c-68efecca1642 | 1 | 2018-03-08 |
| 71335-0161-7 | EA - Each | 71335-0161 | 37debf84-fa45-44ea-875c-8ad855e417d9 | 1 | 2018-03-08 |
| 71335-0161-8 | EA - Each | 71335-0161 | 3a426481-adbe-432e-b079-fb5003cdcc0e | 1 | 2018-03-08 |
| 71335-0161-9 | EA - Each | 71335-0161 | 6880c822-9f27-45e5-a0f2-d36270902786 | 1 | 2018-03-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | Preferred Pharmaceuticals, Inc. | 70bc6f36-8087-4ccd-a396-a911c0ebae79 | 2026-08-17 | Warnings, Adverse reactions | 0K2I505OTV |
| Phentermine hydrochloride | PHENTERMINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 129e781c-5366-4986-8e67-6b35fa4c3f39 | 2026-08-17 | Warnings, Adverse reactions | 803353 0K2I505OTV |
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | d77f31b4-7e36-4a0a-a55b-78b4b6ab5cb7 | 2026-08-17 | Warnings, Adverse reactions | 0K2I505OTV |
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | Northwind Health Company, LLC | 5528d9f7-45ad-d323-e063-6394a90a3e09 | 2026-06-25 | Warnings, Adverse reactions | 803353 0K2I505OTV |
| PHENTERMINE HYDROCHLORIDE | PHENTERMINE HYDROCHLORIDE | Aurolife Pharma LLC | 5927e0f6-3de3-4885-a633-5b92003f6fe4 | 2026-06-10 | Warnings, Adverse reactions | 803353 0K2I505OTV |
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 19f1ce79-65f4-4bf4-a9ff-6ca0a131530f | 2026-06-02 | Warnings, Adverse reactions | ANDA200272 803353 0K2I505OTV |
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 130e6087-0ab6-4456-a781-d370f363dc38 | 2026-06-01 | Warnings, Adverse reactions | 0K2I505OTV |
| LOMAIRA | PHENTERMINE HYDROCHLORIDE | Calvin Scott & Co., Inc. | 0718f0f3-77f2-45d7-be12-1ed718c8b806 | 2026-05-21 | Warnings, Adverse reactions | 0K2I505OTV |
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | Calvin Scott & Co., Inc. | d24aaa53-9c78-4c1b-9495-c785a9cf2b26 | 2026-05-21 | Warnings, Adverse reactions | 0K2I505OTV |
| Phentermine | PHENTERMINE HYDROCHLORIDE | Calvin Scott & Co., Inc. | 27e88ebe-6247-4598-8ef2-c882992ed579 | 2026-05-21 | Warnings, Adverse reactions | 0K2I505OTV |
| Phentermine hydrochloride | PHENTERMINE HYDROCHLORIDE | Calvin Scott & Co., Inc. | 3d1d4dde-1c7f-4a20-b8f8-897b1b284f80 | 2026-05-21 | Warnings, Adverse reactions | 803353 0K2I505OTV |
| phentermine and topiramate | PHENTERMINE AND TOPIRAMATE | Prasco Laboratories | 876bd763-13fa-481e-b579-c2fc44dbf3c2 | 2026-05-18 | Warnings, Adverse reactions | 0K2I505OTV |
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | Bryant Ranch Prepack | d95e14f7-a46d-47fa-8dab-ee3d8d4c7b6d | 2026-05-12 | Warnings, Adverse reactions | 0K2I505OTV |
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | Bryant Ranch Prepack | e6939fcf-3db2-492a-99ed-a384cdeea7a2 | 2026-05-11 | Warnings, Adverse reactions | ANDA200272 803353 0K2I505OTV |
| Qsymia | PHENTERMINE AND TOPIRAMATE | Vivus LLC | 40dd5602-53da-45ac-bb4b-15789aba40f9 | 2026-04-22 | Warnings, Adverse reactions | 0K2I505OTV |
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | eae1d7f9-733c-434b-9199-5f7052e541da | 2026-04-14 | Warnings, Adverse reactions | 803353 0K2I505OTV |
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | Bryant Ranch Prepack | 328d6a39-34f4-4b74-a1bf-6ec6005b1322 | 2026-04-01 | Warnings, Adverse reactions | ANDA200272 803353 0K2I505OTV |
| Phentermine and Topiramate Extended-Release | PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE | Dr.Reddys Laboratories Inc | 260c3f90-163d-0bdd-1099-55d18a900e68 | 2026-03-31 | Warnings, Adverse reactions | 0K2I505OTV |
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | b425840f-380e-42bd-852a-6ee3641977ce | 2026-03-23 | Warnings, Adverse reactions | 0K2I505OTV |
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | Bryant Ranch Prepack | e48feec6-50c9-4ccd-b9da-56956d14c853 | 2026-03-18 | Warnings, Adverse reactions | 0K2I505OTV |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.